logo

Ultragenyx Pharmaceutical Inc (RARE)



Trade RARE now with
  Date
  Headline
2/19/2019 5:20:47 PM Ultragenyx Pharma Q4 Loss/share $1.73 Vs. Loss $1.89 Year Ago
2/4/2019 8:34:32 AM Ultragenyx Appoints Shehnaaz Suliman To Board
1/7/2019 7:35:27 AM Wedbush Reiterates Ultragenyx Pharmaceutical Inc (RARE) At Outperform With $88 Price Target
1/4/2019 8:34:43 AM Ultragenyx Reports Results From First Cohort Of Phase1/2 Study Of DTX401 GeneTherapy In Glycogen Storage Disease Type Ia
12/6/2018 8:39:50 AM Ultragenyx And Kyowa Kirin Announce Health Canada Approval Of Crysvita
11/14/2018 8:32:17 AM Ultragenyx To Submit NDA To FDA For UX007 For Treatment Of Long-chain Fatty Acid Oxidation Disorders In Mid-2019
11/6/2018 9:14:37 AM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) 2019 Estimate To -6.79 From -7.70
11/6/2018 9:14:24 AM Wedbush Is Increasing Ultragenyx Pharmaceutical Inc (RARE) 4Q19 Estimate To -1.66 From -1.89
11/6/2018 9:14:12 AM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) 3Q19 Estimate To -1.69 From -1.92
11/6/2018 9:14:00 AM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) 2Q19 Estimate To -1.71 From -1.94
11/6/2018 9:13:46 AM Wedbush Is Increasing Ultragenyx Pharmaceutical Inc (RARE) 1Q19 Estimate To -1.72 From -1.94
11/6/2018 9:13:33 AM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) 2018 Estimate To -3.95 From -4.45
11/6/2018 9:13:17 AM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) 4Q18 Estimate To -1.78 From -2.03
11/6/2018 9:12:57 AM Wedbush Is Increasing Ultragenyx Pharmaceutical Inc (RARE) 2019 Rev. Estimate To 78.0 M From 74.9 M
11/6/2018 9:12:41 AM Wedbush Is Increasing Ultragenyx Pharmaceutical Inc (RARE) 4Q19 Rev. Estimate To 26.9 M From 26.0 M
11/6/2018 9:12:31 AM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) 3Q19 Rev. Estimate To 21.2 M From 20.4 M
11/6/2018 9:12:22 AM Wedbush Is Increasing Ultragenyx Pharmaceutical Inc (RARE) 2Q19 Rev. Estimate To 16.7 M From 16.0 M
11/6/2018 9:12:14 AM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) 1Q19 Rev. Estimate To 13.2 M From 12.5 M